IFN-γ: A cytokine at the right time, is in the right place
J Daniel Burke1, Howard A Young2
1AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Insights
Interferon gamma (IFN-γ) is crucial for anti-tumor immunity. This review explores how IFN-γ overcomes tumor-induced immunosuppression and discusses strategies to enhance immunotherapy by modulating the tumor microenvironment.
Area of Science:
- Immunology
- Cancer Research
- Oncology
Background:
- Interferon gamma (IFN-γ) is a key cytokine in tumor immunity.
- The tumor microenvironment's complexity impacts immunotherapy efficacy.
- IFN-γ and related factors predict immunotherapy success.
Purpose of the Study:
- To review the immunosuppressive barriers IFN-γ faces in eliminating tumors.
- To explore strategies for modulating immune responses to favor tumor rejection.
Main Methods:
- Literature review of existing research on IFN-γ and tumor immunity.
- Analysis of cellular interactions within the tumor microenvironment.
- Discussion of current immunotherapy approaches and their relation to IFN-γ.
Main Results:
- IFN-γ must overcome multiple immunosuppressive mechanisms within the tumor.
- Checkpoint inhibitors have improved cancer treatment outcomes.
- IFN-γ remains a strong predictor of successful cancer immunotherapy.
Conclusions:
- Understanding IFN-γ's role is vital for improving cancer immunotherapy.
- Targeting immunosuppressive barriers can enhance anti-tumor immune responses.
- Modulating the immune system in favor of tumor rejection is a promising therapeutic avenue.
Abstract:
Interferon gamma has long been studied as a critical mediator of tumor immunity. In recent years, the complexity of cellular interactions that take place in the tumor microenvironment has become better appreciated in the context of immunotherapy. While checkpoint inhibitors have dramatically improved remission rates in cancer treatment, IFN-γ and related effectors continue to be identified as strong predictors of treatment success. In this review, we provide an overview of the multiple immunosuppressive barriers that IFN-γ has to overcome to eliminate tumors, and potential avenues for modulating the immune response in favor of tumor rejection.
More Related Videos
06:57In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method
Published on: May 30, 2025
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Related Concept Videos
Generation Time
Mixing Time
Mean free path and Mean free time
Time Course of Drug Effect
Setting Time of Cement
Timing and Consequences on Behavior
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
